HemOnc.org - A Free Hematology/Oncology Reference
|Regimens: 2,481||Regimen variants: 3,631|
|Solid Tumors||Malignant Hematology||Cross-Disciplinary||Classical Hematology|
|Mobile Version||Editorial Board||Desktop Version|
|Disease index||Drug index||Regimen index||General reference|
Links to all main disease pages
|back to top|
|back to top|
|B-cell acute lymphoblastic leukemia (B-ALL)||B-ALL, Ph+||Ewing's sarcoma||Neuroblastoma|
|Osteosarcoma||T-cell acute lymphoblastic leukemia (T-ALL)|
|Stem cell mobilization||Allogeneic HSCT||Autologous HSCT||Graft versus host disease (GVHD)|
|back to top|
Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100's of hematology/oncology drugs, and 1000's of treatment regimens. Content is added by hematology & oncology professionals, and undergoes continuous peer review.
Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details.
Priorities of this project include:
- Creating a database of all FDA-approved chemotherapy agents and supportive medications used in the field of hematology/oncology.
- Creating a database of all standard-of-care chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
- Sample order sets and examples of supportive medications used with treatment regimens
- Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.
Additional possibilities for this project may include:
- Creating summaries of pivotal clinical trials
- Prioritizing regimens by their efficacy and/or toxicity
- Capturing historical regimens that were standard-of-care prior to 2005
- Checklists for common clinical scenarios/diseases
- Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.